Proteomic screening of variola virus reveals a unique NF-κB inhibitor that is highly conserved among pathogenic orthopoxviruses

Identification of the binary interactions between viral and host proteins has become a valuable tool for investigating viral tropism and pathogenesis. Here, we present the first systematic protein interaction screening of the unique variola virus proteome by using yeast 2-hybrid screening against a variety of human cDNA libraries. Several protein–protein interactions were identified, including an interaction between variola G1R, an ankryin/F-box containing protein, and human nuclear factor kappa-B1 (NF-κB1)/p105. This represents the first direct interaction between a pathogen-encoded protein and NF-κB1/p105. Orthologs of G1R are present in a variety of pathogenic orthopoxviruses, but not in vaccinia virus, and expression of any one of these viral proteins blocks NF-κB signaling in human cells. Thus, proteomic screening of variola virus has the potential to uncover modulators of the human innate antiviral responses.

[1]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[2]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[3]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[4]  J. Shisler,et al.  The Vaccinia Virus K1L Gene Product Inhibits Host NF-κB Activation by Preventing IκBα Degradation , 2004, Journal of Virology.

[5]  Avram Hershko,et al.  The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). , 2005, Angewandte Chemie.

[6]  S. Ley,et al.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. , 2004, The Biochemical journal.

[7]  T. Pawson,et al.  Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes , 2008, Proceedings of the National Academy of Sciences.

[8]  Charles A. Wartchow,et al.  Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. , 1996, Clinical chemistry.

[9]  R. Bram,et al.  Kaposi's Sarcoma-Associated Herpesvirus Mitochondrial K7 Protein Targets a Cellular Calcium-Modulating Cyclophilin Ligand To Modulate Intracellular Calcium Concentration and Inhibit Apoptosis , 2002, Journal of Virology.

[10]  R. Erikson,et al.  Polo-like kinase 3 is required for entry into S phase , 2007, Proceedings of the National Academy of Sciences.

[11]  G. McFadden,et al.  Host-related immunomodulators encoded by poxviruses and herpesviruses. , 2000, Current opinion in microbiology.

[12]  R. Bram,et al.  Calcium signalling in T cells stimulated by a cyclophilin B-binding protein , 1994, Nature.

[13]  J. Shisler,et al.  Poxviral Regulation of the Host NF-κB Response: the Vaccinia Virus M2L Protein Inhibits Induction of NF-κB Activation via an ERK2 Pathway in Virus-Infected Human Embryonic Kidney Cells , 2006, Journal of Virology.

[14]  F. Oppenheim,et al.  Molecular cloning of a novel high molecular weight mucin (MG1) from human sublingual gland. , 1995, Biochemical and biophysical research communications.

[15]  B. Moss,et al.  Immunology 101 at poxvirus U: immune evasion genes. , 2001, Seminars in immunology.

[16]  A. Bowie,et al.  The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. , 2008, Biochemical pharmacology.

[17]  W. Bushman,et al.  Control of directionality in lambda site specific recombination. , 1985, Science.

[18]  J. Shisler,et al.  The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. , 2004, Journal of virology.

[19]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[20]  A. Bowie,et al.  An arms race: innate antiviral responses and counteracting viral strategies. , 2007, Biochemical Society transactions.

[21]  D. Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. , 2006, Journal of immunology.

[22]  I. Haga,et al.  Evasion of innate immunity by vaccinia virus , 2005, Parasitology.

[23]  D. Haig.  Subversion and piracy: DNA viruses and immune evasion. , 2001, Research in veterinary science.

[24]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[25]  G. McFadden,et al.  Immunomodulatory proteins of myxoma virus. , 2001, Seminars in immunology.

[26]  S. Ley,et al.  New insights into NF-kappaB regulation and function. , 2008, Trends in immunology.

[27]  P. Greengard,et al.  Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Frank Gesellchen,et al.  Quantification of cAMP antagonist action in vitro and in living cells. , 2006, European journal of cell biology.

[29]  Liping Huang,et al.  The ZIP7 Gene (Slc39a7) Encodes a Zinc Transporter Involved in Zinc Homeostasis of the Golgi Apparatus* , 2005, Journal of Biological Chemistry.

[30]  S. Fields,et al.  Genome-wide analysis of vaccinia virus protein-protein interactions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Finke,et al.  Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter , 1999, Journal of Virology.

[32]  G. McFadden,et al.  Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells. , 2007, Virology.

[33]  E. F. Ullman,et al.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Fields,et al.  The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[36]  M. Gale,et al.  Viral regulation and evasion of the host response. , 2007, Current topics in microbiology and immunology.

[37]  A. Kerlavage,et al.  Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. , 1994, Virology.

[38]  D A Henderson,et al.  The looming threat of bioterrorism. , 1999, Science.

[39]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[40]  Katherine A. Oehlberg,et al.  Variola virus immune evasion proteins. , 2003, Microbes and infection.

[41]  Geoffrey L. Smith,et al.  Vaccinia virus immune evasion. , 1999, Immunology letters.

[42]  Kevin F. Jones,et al.  Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination , 2007, Vaccine.

[43]  Janina Maier,et al.  Guide to yeast genetics and molecular biology. , 1991, Methods in enzymology.

[44]  Bhupinder Bhullar,et al.  Self-Assembling Protein Microarrays , 2004, Science.

[45]  G. McFadden,et al.  Smallpox: anything to declare? , 2002, Nature Reviews Immunology.

[46]  Peer Bork,et al.  SMART 5: domains in the context of genomes and networks , 2005, Nucleic Acids Res..

[47]  M. Ptashne.  A genetic switch : phage λ and higher organisms , 1992 .

[48]  Margarida Saraiva,et al.  A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Mercer,et al.  F-Box-Like Domains are Present in Most Poxvirus Ankyrin Repeat Proteins , 2005, Virus Genes.

[50]  Y. Xiong,et al.  Ectromelia Virus Encodes a Novel Family of F-Box Proteins That Interact with the SCF Complex , 2008, Journal of Virology.

[51]  松峯 昭彦.  MCC, a cytoplasmic protein that blocks cell cycle progression from the G0/G1 to S phase , 1996 .

[52]  G. McFadden,et al.  Poxviruses and immune evasion. , 2003, Annual review of immunology.

[53]  A. Alcamí.  New insights into the subversion of the chemokine system by poxviruses , 2007, European journal of immunology.